4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001562180-19-003624
Chief Business Officer sold 5,415 shares at $16.07 ($87,019)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ISACSON CHRISTINA K. Chief Business Officer | 2019-06-21 | Sale | −5,415 | $16.07 | $87,019 | 98,116 | D |
| Open-market sales · 5,415 sh · avg $16.07 · $87,019 | |||||||
Loading xslF345X03/primarydocument.xml…